Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hendrik Maarten Vinkers is active.

Publication


Featured researches published by Hendrik Maarten Vinkers.


Talanta | 2005

Improving QSAR models for the biological activity of HIV Reverse Transcriptase inhibitors: Aspects of outlier detection and uninformative variable elimination

M. Daszykowski; I. Stanimirova; B. Walczak; Frits Daeyaert; M.R. de Jonge; Jan Heeres; Lucien Maria Henricus Koymans; Paulus Joannes Lewi; Hendrik Maarten Vinkers; Paul A. J. Janssen; D.L. Massart

The goal of this study is to derive a methodology for modeling the biological activity of non-nucleoside HIV Reverse Transcriptase (RT) inhibitors. The difficulties that were encountered during the modeling attempts are discussed, together with their origin and solutions. With the selected multivariate techniques: robust principal component analysis, partial least squares, robust partial least squares and uninformative variable elimination partial least squares, it is possible to explore and to model the contaminated data satisfactory. It is shown that these techniques are versatile and valuable tools in modeling and exploring biochemical data.


Journal of Computer-aided Molecular Design | 2003

Inhibition and substrate recognition: a computational approach applied to HIV protease

Hendrik Maarten Vinkers; M.R. de Jonge; Frits Daeyaert; Jan Heeres; Lucien Maria Henricus Koymans; J.H. van Lenthe; Paulus Joannes Lewi; H. Timmerman; Paul A. J. Janssen

We have developed a computational approach in which an inhibitors strength is determined from its interaction energy with a limited set of amino acid residues of the inhibited protein. We applied this method to HIV protease. The method uses a consensus structure built from X-ray crystallographic data. All inhibitors are docked into the consensus structure. Given that not every ligand–protein interaction causes inhibition, we implemented a genetic algorithm to determine the relevant set of residues. The algorithm optimizes the q2 between the sum of interaction energies and the observed inhibition constants. The best possible predictive model resulting has a q2 of 0.63. External validation by examining the predictivity for compounds not used in derivation of the model leads to a prediction accuracy between 0.9 and 1.5 log10 unit. Out of 198 residues in the whole protein, the best internally predictive model defines a subset of 20 residues and the best externally predictive model one of 9 residues. These residues are distributed over the subsites of the enzyme. This approach provides insight in which interactions are important for inhibiting HIV protease and it allows for quantitative prediction of inhibitor strength.


Archive | 2002

Hiv inhibiting pyrimidines derivatives

Jérôme Emile Georges Guillemont; Patrice Palandjian; Marc René De Jonge; Lucien Maria Henricus Koymans; Hendrik Maarten Vinkers; Frederik Frans Desiré Daeyaert; Jan Heeres; Koen Jeanne Alfons Van Aken; Paulus Joannes Lewi; Paul A. J. Janssen


Archive | 2002

Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)

Eddy Jean Edgard Freyne; Peter Jacobus Johannes Antonius Buijnsters; Marc Willems; Werner Constant Johan Embrechts; Christopher John Love; Paul A. J. Janssen; Paulus Joannes Lewi; Jan Heeres; Marc René De Jonge; Lucien Maria Henricus Koymans; Hendrik Maarten Vinkers; Koen Jeanne Alfons Van Aken; Gaston Stanislas Marcella Diels


Archive | 2004

Pyrimidine derivatives for the prevention of HIV infection

Jan Heeres; Paulus Joannes Lewi; Jonge Marc Rene De; Lucien Maria Henricus Koymans; Frederik Frans Desiré Daeyaert; Hendrik Maarten Vinkers; Jérôme Emile Georges Guillemont; Elisabeth Thérèse Jeanne Pasquier; Paul A. J. Janssen


Archive | 2004

HIV replication inhibiting purine derivatives

Paulus Joannes Lewi; Jonge Marc Rene De; Lucien Maria Henricus Koymans; Frederik Frans Desiré Daeyaert; Jan Heeres; Hendrik Maarten Vinkers; Ruben Gerardus George Leenders; Dirk Alfons Leo Vandenput; Paul A. J. Janssen


Chemometrics and Intelligent Laboratory Systems | 2004

Multivariate adaptive regression splines—studies of HIV reverse transcriptase inhibitors

Qing-Song Xu; Michael Daszykowski; B. Walczak; Frits Daeyaert; M.R. de Jonge; Jan Heeres; Lucien Maria Henricus Koymans; Paulus Joannes Lewi; Hendrik Maarten Vinkers; Paul A. J. Janssen; D.L. Massart


Archive | 2004

Hiv inhibiting 1,2,4-triazines

Paulus Joannes Lewi; Paul A. J. Janssen; Marc René De Jonge; Lucien Maria Henricus Koymans; Hendrik Maarten Vinkers; Frederik Frans Desiré Daeyaert; Jan Heeres; Ruben Gerardus George Leenders; Georges Joseph Cornelius Hoomaert; Amuri Kilonda; Donald William Ludovici


Archive | 2005

HIV inhibiting 1,2,4-triazin-6-one derivatives

Georges Joseph Cornelius Hoornaert; Amuri Kilonda; Jan Heeres; Paulus Joannes Lewi; Marc René De Jonge; Frederik Frans Desiré Daeyaert; Hendrik Maarten Vinkers; Lucien Maria Henricus Koymans; Paul A. J. Janssen


Archive | 2014

Pyrimidine derivative for prevention of hiv infection

Adrian Jean Janssen Paul; パウル・アドリアーン・ジヤン・ジヤンセン; Jan Heeres; ヤン・ヘーレス; Joannes Lewi Paulus; パウルス・ヨアネス・レビ; Jonge Marc Rene De; マルク・ルネ・ド・ヨング; Lucien Maria Henrikus Koymans; ルシアン・マリア・ヘンリクス・コイマン; Frederik Frans Desire Daeyaert; フレデリク・フラン・デジレ・デヤルト; Hendrik Maarten Vinkers; ヘンドリク・マールテン・ビンカース; Jerome Emile George Guillemont; ジエローム・エミール・ジヨルジユ・ギルモン; Elisabeth Thérèse Jeanne Pasquier; エリザベト・テレーズ・ジヤンヌ・パスキエ

Collaboration


Dive into the Hendrik Maarten Vinkers's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amuri Kilonda

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge